Hobart Private Capital, LLC Abb Vie Inc. Transaction History

Hobart Private Capital, LLC

$328 Billion
Q1 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Mar 11, 2024	SELL	$107.43 - $135.93 $714,731 - $904,342	-6,653 Closed	0 $0
Q3 2021 Mar 11, 2024	SELL	$106.4 - $120.78 $309,943 - $351,832	-2,913 Reduced 30.45%	6,653 $718 Million
Q2 2021 Mar 11, 2024	SELL	$105.21 - $117.21 $33,141 - $36,921	-315 Reduced 3.19%	9,566 $1.08 Billion
Q1 2021 Mar 11, 2024	BUY	$102.3 - $112.62 $1.01 Million - $1.11 Million	9,881 New	9,881 $1.07 Billion
Q4 2020 Mar 11, 2024	SELL	$80.49 - $108.67 $67,209 - $90,739	-835 Reduced 7.33%	10,560 $1.13 Billion

Q3 2020 Mar 11, 2024	SELL	$85.91 - $100.83 $540,202 - $634,019	-6,288 Reduced 35.56%	11,395 $998 Million
Q2 2020 Mar 11, 2024	SELL	$73.37 - $98.18 $462,451 - $618,828	-6,303 Reduced 26.28%	17,683 $1.74 Billion
Q1 2020 Mar 11, 2024	SELL	$64.5 - $97.79 $38,829 - $58,869	-602 Reduced 2.45%	23,986 $1.83 Billion
Q4 2019 Mar 11, 2024	BUY	$72.13 - $90.25 $1.77 Million - $2.22 Million	24,588 New	24,588 $2.18 Billion
Q3 2019 Mar 11, 2024	BUY	$62.98 - $75.72 $206,700 - $248,513	3,282 Added 16.23%	23,505 $1.78 Billion
Q2 2019 Mar 11, 2024	BUY	$65.7 - $83.98 $81,205 - $103,799	1,236 Added 6.51%	20,223 $1.47 Billion
Q1 2019 Mar 11, 2024	SELL	$77.14 - $90.79 $90,330 - $106,315	-1,171 Reduced 5.81%	18,987 $1.53 Billion
Q4 2018 Mar 11, 2024	BUY	$77.85 - $96.01 $994,222 - $1.23 Million	12,771 Added 172.88%	20,158 $1.86 Billion
Q3 2018 Mar 11, 2024	SELL	$88.91 - $98.84 $1,333 - $1,482	-15 Reduced 0.2%	7,387 $699 Million
Q2 2018 Mar 11, 2024	SELL	$89.78 - $106.23 $325,811 - $385,508	-3,629 Reduced 32.9%	7,402 $686 Million
Q1 2018 Mar 11, 2024	BUY	$92.01 - $123.21 $1.01 Million - $1.36 Million	11,031 New	11,031 $1.04 Billion
Q4 2017 Mar 11, 2024	BUY	$89.56 - $98.21 $1.6 Million - $1.75 Million	17,836	17,836 $1.72 Billion

Others Institutions Holding ABBV

# of Institutions

3,653

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

Vanguard Group Inc Valley Forge, PA

170M
Shares

$28.5 Billion
0.62% of portfolio
Black Rock Inc. New York, NY

143M
Shares

$23.9 Billion
0.61% of portfolio
State Street Corp Boston, MA

78M
Shares

$13 Billion
0.64% of portfolio
Jpmorgan Chase & CO New York, NY

51.3M
Shares

$8.57 Billion
0.85% of portfolio
Capital International Investors Los Angeles, CA

48.1M
Shares

$8.04 Billion
1.81% of portfolio

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $296B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hobart Private Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hobart Private Capital, LLC with notifications on news.

Account